AlphaMadera's AlphaVal page computes Global Medical REIT Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag GMRE as undervalued, fairly valued, or overvalued.

What is Global Medical REIT Inc.'s fair value?

Fair value for GMRE is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value GMRE?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from GMRE's most recent reported fundamentals.

GMRE - Global Medical REIT Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $20.92 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Real Estate Investment Trust 85% confidence

Primary model: P/FFO × Healthcare REIT Multiple

Valuation Signal Undervalued Moderate

Trading 35.5% below fair value

Current Price $35.74

Bear Case $43.08 20.5% upside ($43.08 - $35.74) / $35.74 = 20.5% $3.43 FFO × 15x

Fair Value $55.39 55.0% upside ($55.39 - $35.74) / $35.74 = 55.0% $3.43 FFO × 19x

Bull Case $67.70 89.4% upside ($67.70 - $35.74) / $35.74 = 89.4% $3.43 FFO × 24x

Adjust Assumptions

P/FFO Multiple

19.5x

FFO per Share

3.43$

Key Value Driver

FFO/share ($3.43) × healthcare P/FFO multiple

Implied Market Multiple 10.4x

Plain-Language Summary

Our base-case estimate uses P/FFO × Healthcare REIT Multiple. We then blend that result with the average analyst price target of $20.92 from 22 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $55.39 per share.

Warnings

⚠ Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.

ℹ Wall Street's average price target is $20.92 (from 22 analysts). Our estimate is 220% above the consensus -- consider that gap carefully.

Key Risks

P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
Interest rate sensitivity: REIT multiples compress when rates rise
FFO approximation (NI + D&A) may include gains on property sales — verify